PortfoliosLab logoPortfoliosLab logo
TCRX vs. CWCO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TCRX vs. CWCO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TScan Therapeutics, Inc. (TCRX) and Consolidated Water Co. Ltd. (CWCO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TCRX achieves a -7.90% return, which is significantly higher than CWCO's -15.89% return.


TCRX

1D
6.46%
1M
-13.11%
YTD
-7.90%
6M
1.13%
1Y
-36.48%
3Y*
-30.13%
5Y*
10Y*

CWCO

1D
1.45%
1M
0.10%
YTD
-15.89%
6M
-17.06%
1Y
-0.30%
3Y*
10.26%
5Y*
21.36%
10Y*
10.89%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TCRX vs. CWCO - Yearly Performance Comparison


2026 (YTD)20252024202320222021
TCRX
TScan Therapeutics, Inc.
-7.90%-67.11%-47.86%276.13%-65.56%-62.50%
CWCO
Consolidated Water Co. Ltd.
-15.89%38.70%-26.46%144.17%42.62%-11.01%

Correlation

The correlation between TCRX and CWCO is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Jul 16, 2021

0.12

The correlation between TCRX and CWCO shifts across timeframes, from 0.12 (all time) to 0.23 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

EPS

TCRX:

-$0.96

CWCO:

$1.44

PS Ratio

TCRX:

14.67

CWCO:

2.75

Total Revenue (TTM)

TCRX:

$8.15M

CWCO:

$128.33M

Gross Profit (TTM)

TCRX:

$6.66M

CWCO:

$46.99M

EBITDA (TTM)

TCRX:

-$129.32M

CWCO:

$22.17M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TCRX vs. CWCO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TCRX
TCRX Risk / Return Rank: 2626
Overall Rank
TCRX Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
TCRX Sortino Ratio Rank: 2929
Sortino Ratio Rank
TCRX Omega Ratio Rank: 2929
Omega Ratio Rank
TCRX Calmar Ratio Rank: 2323
Calmar Ratio Rank
TCRX Martin Ratio Rank: 2727
Martin Ratio Rank

CWCO
CWCO Risk / Return Rank: 3939
Overall Rank
CWCO Sharpe Ratio Rank: 4242
Sharpe Ratio Rank
CWCO Sortino Ratio Rank: 3737
Sortino Ratio Rank
CWCO Omega Ratio Rank: 3636
Omega Ratio Rank
CWCO Calmar Ratio Rank: 4242
Calmar Ratio Rank
CWCO Martin Ratio Rank: 4242
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TCRX vs. CWCO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TScan Therapeutics, Inc. (TCRX) and Consolidated Water Co. Ltd. (CWCO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TCRXCWCODifference
Sharpe ratioReturn per unit of total volatility

-0.42

Sortino ratioReturn per unit of downside risk

-0.31

Omega ratioGain probability vs. loss probability

0.99

1.03

-0.04

Calmar ratioReturn relative to maximum drawdown

-0.55

-0.01

-0.54

Martin ratioReturn relative to average drawdown

-0.79

-0.03

-0.76

TCRX vs. CWCO - Sharpe Ratio Comparison

The current TCRX Sharpe Ratio is -0.43, which is lower than the CWCO Sharpe Ratio of -0.01. The chart below compares the historical Sharpe Ratios of TCRX and CWCO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TCRX vs. CWCO - Drawdown Comparison

The maximum TCRX drawdown since its inception was -93.71%, which is greater than CWCO's maximum drawdown of -81.47%. Use the drawdown chart below to compare losses from any high point for TCRX and CWCO.


Loading charts...

Drawdown Indicators


TCRXCWCODifference

Max Drawdown

Largest peak-to-trough decline

-93.71%

-81.47%

-12.24%

Max Drawdown (1Y)

Largest decline over 1 year

-66.35%

-25.29%

-41.06%

Max Drawdown (3Y)

Largest decline over 3 years

-91.08%

-38.23%

-52.85%

Max Drawdown (5Y)

Largest decline over 5 years

-38.23%

Max Drawdown (10Y)

Largest decline over 10 years

-47.74%

Current Drawdown

Current decline from peak

-93.17%

-23.07%

-70.10%

Average Drawdown

Average peak-to-trough decline

-72.16%

-38.25%

-33.91%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.35%

10.23%

+36.12%

Volatility

TCRX vs. CWCO - Volatility Comparison

TScan Therapeutics, Inc. (TCRX) has a higher volatility of 20.61% compared to Consolidated Water Co. Ltd. (CWCO) at 6.18%. This indicates that TCRX's price experiences larger fluctuations and is considered to be riskier than CWCO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TCRXCWCODifference

Volatility (1M)

Calculated over the trailing 1-month period

20.61%

6.18%

+14.43%

Volatility (6M)

Calculated over the trailing 6-month period

51.24%

22.36%

+28.88%

Volatility (1Y)

Calculated over the trailing 1-year period

86.11%

29.97%

+56.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

98.15%

37.34%

+60.81%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

98.15%

37.90%

+60.25%

Dividends

TCRX vs. CWCO - Dividend Comparison

TCRX has not paid dividends to shareholders, while CWCO's dividend yield for the trailing twelve months is around 1.90%.


PositionTTM20252024202320222021202020192018201720162015
CWCO
Consolidated Water Co. Ltd.
1.90%1.42%1.16%1.01%2.30%3.20%2.82%2.09%3.64%1.79%2.76%2.45%
TCRX
TScan Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

TCRX vs. CWCO - Financials Comparison

This section allows you to compare key financial metrics between TScan Therapeutics, Inc. and Consolidated Water Co. Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00M202220232024202520260
29.97M
(TCRX) Total Revenue
(CWCO) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TCRX and CWCO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TCRX has higher volatility (20.61%) compared to CWCO (6.18%). In terms of maximum drawdown, TCRX dropped -93.71% vs CWCO's -81.47%.

CWCO currently has the higher Sharpe Ratio (-0.01 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TCRX and CWCO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer